Molecular analysis of the TP53 gene in Barrett's adenocarcinoma

Hum Mutat. 1996;7(2):109-13. doi: 10.1002/(SICI)1098-1004(1996)7:2<109::AID-HUMU4>3.0.CO;2-7.

Abstract

The TP53 gene is the most frequently mutated gene in human cancers. Barrett's esophagus provides an excellent model by which to understand the genetic events that lead from dysplasia to cancer. We screened for mutations in the TP53 gene by a combination of denaturing gradient gel electrophoresis and DNA sequencing in ten cases of adenocarcinoma arising in Barrett's mucosa. We have identified missense mutations in five of the ten samples, three transitions (R282W, G245S, R248W) and two transversions (E286Q and C176F). In one case we have analyzed biopsy specimens taken from the same site, one year before the patient developed an intra mucosal carcinoma. The mutation that was identified in this high grade dysplastic area was identical to that detected in the cancer. This would suggest TP53 mutations occur as an early genetic event in the development of Barrett's adenocarcinoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / genetics*
  • Adenocarcinoma / pathology
  • Barrett Esophagus / genetics*
  • Barrett Esophagus / pathology
  • Base Sequence
  • DNA Primers
  • Electrophoresis, Polyacrylamide Gel
  • Esophageal Neoplasms / genetics*
  • Esophageal Neoplasms / pathology
  • Exons
  • Female
  • Genes, p53 / genetics*
  • Humans
  • Male
  • Molecular Sequence Data
  • Mutation
  • Neoplasm Staging
  • Nucleic Acid Denaturation
  • Polymerase Chain Reaction
  • Sequence Analysis

Substances

  • DNA Primers